| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 20 |
| 1 | APIXABAN | 9 |
| 2 | FUROSEMIDE | 8 |
| 3 | ASPIRIN | 6 |
| 4 | ASPIRIN 325 MG | 6 |
| 5 | ASPIRIN 81 MG | 6 |
| 6 | LISINOPRIL | 6 |
| 7 | WARFARIN | 6 |
| 8 | SERTRALINE | 5 |
| 9 | CLOPIDOGREL | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DONANEMAB-AZBT | 3 | 0.0010 |
| 1 | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | 3 | 0.0009 |
| 2 | PIOGLITAZONE HYDROCHLORIDE | 1 | 0.0008 |
| 3 | AZILSARTAN KAMEDOXOMIL AND CHLORTHALIDONE | 1 | 0.0008 |
| 4 | AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE | 3 | 0.0007 |
| 5 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | 3 | 0.0007 |
| 6 | CILOSTAZOL | 3 | 0.0005 |
| 7 | DEXMEDETOMIDINE HYDROCHLORIDE | 1 | 0.0003 |
| 8 | CLINDAMYCIN PHOSPHATE TOPICAL | 1 | 0.0003 |
| 9 | LECANEMAB | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Phosphodiesterase 3 Inhibitor [EPC] | 3 | 0.0005 |
| 1 | Amyloid Beta-directed Antibody [EPC] | 1 | 0.0003 |
| 2 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 3 | Antifibrinolytic Agent [EPC] | 2 | 0.0002 |
| 4 | Factor Xa Inhibitor [EPC] | 37 | 0.0001 |
| 5 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 6 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 7 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Methylxanthine [EPC] | 3 | 0.0001 |
| 9 | Topoisomerase Inhibitor [EPC] | 3 | 0.0000 |